H. Brötz

发表

New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular target.

H. Sahl, H. Brötz, 2000, The Journal of antimicrobial chemotherapy.

The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II

H. Sahl, P. Reynolds, G. Bierbaum, 1998, Antimicrobial Agents and Chemotherapy.

Bacillus subtilis Tolerance of Moderate Concentrations of Rifampin Involves the σB-Dependent General and Multiple Stress Response

M. Hecker, J. Bandow, H. Brötz, 2002, Journal of bacteriology.

The role of peptide deformylase in protein biosynthesis: A proteomic study

M. Hecker, J. Bandow, D. Becher, 2003, Proteomics.

Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?

H. Sahl, G. Bierbaum, H. Brötz, 1995, Antimicrobial agents and chemotherapy.

Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics

H. Sahl, F. Götz, G. Bierbaum, 1998, Molecular microbiology.

The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.

H. Sahl, P. Reynolds, G. Bierbaum, 1997, European journal of biochemistry.

Proteomic Approach to Understanding Antibiotic Action

Harald Labischinski, Michael Hecker, M. Hecker, 2003, Antimicrobial Agents and Chemotherapy.

Identification of novel essential Escherichia coli genes conserved among pathogenic bacteria.

B Wieland, F. Spaltmann, H. Labischinski, 2001, Journal of molecular microbiology and biotechnology.

Cloning, sequencing and production of the lantibiotic mersacidin.

H. Sahl, G. Bierbaum, H. Brötz, 1995, FEMS microbiology letters.